Phio Financial Statements From 2010 to 2026

Phio Pharmaceuticals Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 12 M 6.6 M 10.1 M Slightly volatile Short and Long Term Debt Total 29.9 K 31.5 K 349.3 K Slightly volatile Other Current Liabilities 1.4 M 876.3 K 1.2 M Pretty Stable Total Current Liabilities 1.6 M 913.5 K 1.9 M Pretty Stable Property Plant And Equipment Net 2.2 K 2.3 K 238.1 K Slightly volatile Current Deferred Revenue 1.5 M 1.4 M 950.3 K Slightly volatile Accounts Payable 276.4 K 290.9 K 520.9 K Very volatile Cash 10.4 M 6.2 M 8.8 M Slightly volatile Non Current Assets Total 2.2 K 2.3 K 258.2 K Slightly volatile Cash And Short Term Investments 11.1 M 6.2 M 9.4 M Slightly volatile Net Receivables 477.6 K 537.3 K 586.5 K Slightly volatile Common Stock Total Equity 855 900 3.5 K Slightly volatile Common Stock Shares Outstanding 9.5 M 9.1 M 1.6 M Slightly volatile Liabilities And Stockholders Equity 12 M 6.6 M 10.1 M Slightly volatile Other Current Assets 490.2 K 407.1 K 433.8 K Slightly volatile Other Stockholder Equity 95.3 M 173.7 M 87.5 M Slightly volatile Total Liabilities 867.8 K 913.5 K 3.3 M Slightly volatile Property Plant And Equipment Gross 403.1 K 354.2 K 367.3 K Slightly volatile Total Current Assets 11.6 M 6.6 M 9.9 M Slightly volatile Short Term Debt 29.9 K 31.5 K 182.6 K Slightly volatile Common Stock 855 900 3.5 K Slightly volatile Other Liabilities 21.6 K 24.3 K 26.5 K Slightly volatile Non Currrent Assets Other 3.3 K 3.5 K 21.9 K Very volatile Preferred Stock Total Equity 3.4 M 3.2 M 4.4 M Slightly volatile Property Plant Equipment 268.2 K 478.4 K 284 K Slightly volatile Net Tangible Assets 26.5 M 25.2 M 14.1 M Slightly volatile Warrants 5.2 M 4.6 M 5.7 M Slightly volatile Capital Surpluse 86 M 134.1 M 84.4 M Slightly volatile Long Term Investments 120 K 135 K 147.4 K Slightly volatile Net Invested Capital 5.2 M 5.4 M 6.1 M Slightly volatile Net Working Capital 10.7 M 5.4 M 6.2 M Slightly volatile Non Current Liabilities Other 282.4 K 265.5 K 360.8 K Slightly volatile Long Term Debt 184.8 K 207.9 K 226.9 K Slightly volatile Long Term Debt Total 184.8 K 207.9 K 226.9 K Slightly volatile
Phio Pharmaceuticals Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 1.7 K 1.8 K 90.4 K Slightly volatile Other Operating Expenses 8.8 M 6.6 M 10.7 M Slightly volatile Research Development 5.5 M 3.3 M 6.6 M Slightly volatile Total Operating Expenses 3.2 M 3.4 M 9.3 M Slightly volatile Selling General Administrative 4.3 M 4.3 M 3.8 M Slightly volatile Cost Of Revenue 4.7 M 3.3 M 6.5 M Slightly volatile Preferred Stock And Other Adjustments 3 M 1.9 M 3.7 M Slightly volatile Interest Income 855 900 7.1 K Slightly volatile Non Recurring 3.8 M 4.2 M 4.6 M Slightly volatile Reconciled Depreciation 38.2 K 40.2 K 79.3 K Pretty Stable Selling And Marketing Expenses 147.2 K 165.6 K 180.8 K Slightly volatile
Phio Pharmaceuticals Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 125.7 K 132.3 K 819.8 K Slightly volatile Begin Period Cash Flow 10.6 M 9.8 M 9.5 M Slightly volatile Depreciation 29.9 K 31.5 K 95.7 K Slightly volatile Capital Expenditures 855 900 49.8 K Slightly volatile End Period Cash Flow 10.5 M 6.2 M 8.8 M Slightly volatile Dividends Paid 4.9 M 4.7 M 2 M Slightly volatile Issuance Of Capital Stock 6.9 M 3.6 M 13 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 275 186 264 Very volatile Dividend Yield 0.0092 0.0096 0.0406 Slightly volatile Stock Based Compensation To Revenue 21.55 16.43 18.3325 Very volatile Capex To Depreciation 0.0312 0.0329 0.544 Pretty Stable Payables Turnover 23.76 16.56 21.5875 Slightly volatile Sales General And Administrative To Revenue 212 202 146 Slightly volatile Research And Ddevelopement To Revenue 94.68 184 140 Slightly volatile Capex To Revenue 2.06 3.09 2.5397 Slightly volatile Cash Per Share 0.75 0.79 111.6 K Slightly volatile Days Payables Outstanding 28.3 22.81 33.5623 Pretty Stable Income Quality 0.67 0.9 0.8455 Slightly volatile Current Ratio 4.27 5.09 4.995 Slightly volatile Capex Per Share 1.0E-4 1.0E-4 1.4 K Slightly volatile Revenue Per Share 5.38 5.67 3.3 K Slightly volatile Interest Debt Per Share 0.17 0.1515 8.3 K Slightly volatile Debt To Assets 0.0041 0.0043 0.0685 Slightly volatile Days Of Payables Outstanding 28.3 22.81 33.5623 Pretty Stable Ebt Per Ebit 0.78 0.87 0.9518 Very volatile Quick Ratio 4.27 5.09 4.995 Slightly volatile Net Income Per E B T 0.7 0.8 0.869 Slightly volatile Cash Ratio 3.84 4.77 4.4777 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.11 1.15 1.0209 Slightly volatile Fixed Asset Turnover 0.0318 0.0335 0.3288 Slightly volatile Debt Ratio 0.0041 0.0043 0.0685 Slightly volatile Price Sales Ratio 275 186 264 Very volatile Asset Turnover 0.0029 0.003 0.0074 Slightly volatile
Phio Pharmaceuticals Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 5.5 M 5.8 M 10.2 M Slightly volatile

Phio Fundamental Market Drivers

Phio Upcoming Events

About Phio Pharmaceuticals Financial Statements

Pair Trading with Phio Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Phio Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.When determining whether Phio Pharmaceuticals Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phio Pharmaceuticals Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phio Pharmaceuticals Corp Stock:

How To Invest In Phio Details

Is Phio Stock a good investment? Details

What is Phio Pharmaceuticals' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details